Please use this identifier to cite or link to this item:
http://hdl.handle.net/11452/30713
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Aydın, Ömer | - |
dc.contributor.author | Büyükkaya, Ramazan | - |
dc.date.accessioned | 2023-01-30T11:39:48Z | - |
dc.date.available | 2023-01-30T11:39:48Z | - |
dc.date.issued | 2017-01-01 | - |
dc.identifier.citation | Aydın, Ö. vd. (2017). ''Contrast medium enhanced susceptibility imaging signal mechanism; should we use contrast medium?''. Acta Radiologica, 58(1), 107-113. | en_US |
dc.identifier.issn | 0284-1851 | - |
dc.identifier.uri | https://doi.org/10.1177/0284185116637246 | - |
dc.identifier.uri | 1600-0455 | - |
dc.identifier.uri | https://journals.sagepub.com/doi/10.1177/0284185116637246 | - |
dc.identifier.uri | http://hdl.handle.net/11452/30713 | - |
dc.description.abstract | Background Intracranial lesions exhibit clear contrast enhancement in T1-weighted imaging, but the mechanism whereby contrast-enhanced susceptibility-weighted imaging (CE-SWI) generates signals remains unclear. Contrast enhancement patterns cannot be reliably predicted. Purpose To explore the mechanism of CE-SWI contrast enhancement. Material and Methods Fifty-five patients were retrospectively enrolled. All of the imaging employed a clinical 3T magnetic resonance imaging (MRI) system fitted with a 32-channel head coil. Minimum-intensity projection reformatted images were evaluated. Intracranial lesions and brain parenchymal intensities were explored using SWI and CE-SWI. signal intensity rates were calculated by dividing the lesional intensity by the white matter intensity, after which the SWI and CE-SWI signal intensity rate were compared. Two observers independently performed intralesional susceptibility signal analysis. Results After contrast medium administration, malignant and extra-axial tumors exhibited obvious contrast enhancement on CE-SWI (P<0.001 and P=0.013, respectively). The signal intensity of white matter was significantly reduced. The signal intensity rates rose significantly in the benign, malignant, and extra-axial groups (P<0.001). Between-radiologist agreement in terms of intralesional susceptibility signal assessment was strong (kappa=0.8, P<0.001). Conclusion Contrast media can either reduce or increase SWI signal intensities. The dual contrast feature of CE-SWI can be useful when exploring intracranial disorders. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Sage Puplications | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Radiology, nuclear medicine & medical imaging | en_US |
dc.subject | Contrast medium | en_US |
dc.subject | Susceptibility weighted imaging | en_US |
dc.subject | Blood brain barrier | en_US |
dc.subject | Angiogenesis | en_US |
dc.subject | Tumor | en_US |
dc.subject | High-resolution | en_US |
dc.subject | Radiation necrosis | en_US |
dc.subject | Grade gliomas | en_US |
dc.subject | Brain | en_US |
dc.subject | Differentiation | en_US |
dc.subject | Patterns | en_US |
dc.subject | Magnetic resonance imaging | en_US |
dc.subject | Tissue | en_US |
dc.subject | Tumors | en_US |
dc.subject | Angiogenesis | en_US |
dc.subject | Blood-brain barrier | en_US |
dc.subject | Contrast enhancement | en_US |
dc.subject | Contrast medium | en_US |
dc.subject | Contrast-enhanced | en_US |
dc.subject | Signal intensities | en_US |
dc.subject | Susceptibility weighted Imaging | en_US |
dc.subject | White matter | en_US |
dc.subject | Contrast media | en_US |
dc.subject.mesh | Adolescent | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Aged | en_US |
dc.subject.mesh | Brain neoplasms | en_US |
dc.subject.mesh | Child | en_US |
dc.subject.mesh | Child, preschool | en_US |
dc.subject.mesh | Contrast media | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Image enhancement | en_US |
dc.subject.mesh | Image interpretation, computer-assisted | en_US |
dc.subject.mesh | Magnetic resonance angiography | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Meglumine | en_US |
dc.subject.mesh | Middle aged | en_US |
dc.subject.mesh | Neovascularization, pathologic | en_US |
dc.subject.mesh | Organometallic compounds | en_US |
dc.subject.mesh | Reproducibility of results | en_US |
dc.subject.mesh | Sensitivity and specificity | en_US |
dc.subject.mesh | Young adult | en_US |
dc.title | Contrast medium enhanced susceptibility imaging signal mechanism; should we use contrast medium? | en_US |
dc.type | Article | en_US |
dc.identifier.wos | 000390557900015 | tr_TR |
dc.identifier.scopus | 2-s2.0-85006483742 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Radyoloji Anabilim Dalı. | tr_TR |
dc.contributor.orcid | 0000-0002-3425-0740 | tr_TR |
dc.identifier.startpage | 107 | tr_TR |
dc.identifier.endpage | 113 | tr_TR |
dc.identifier.volume | 58 | tr_TR |
dc.identifier.issue | 1 | tr_TR |
dc.relation.journal | Acta Radiologica | en_US |
dc.contributor.buuauthor | Hakyemez, Bahattin | - |
dc.contributor.researcherid | AAI-2318-2021 | tr_TR |
dc.relation.collaboration | Yurt içi | tr_TR |
dc.relation.collaboration | Sanayi | tr_TR |
dc.identifier.pubmed | 26966145 | tr_TR |
dc.subject.wos | Radiology, nuclear medicine & medical imaging | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.pubmed | PubMed | en_US |
dc.wos.quartile | Q3 | en_US |
dc.contributor.scopusid | 6602527239 | tr_TR |
dc.subject.scopus | Substantia Nigra; Susceptibility; Pulvinar | en_US |
dc.subject.emtree | Gadoterate meglumine | en_US |
dc.subject.emtree | Contrast medium | en_US |
dc.subject.emtree | Gadoterate meglumine | en_US |
dc.subject.emtree | Meglumine | en_US |
dc.subject.emtree | Organometallic compound | en_US |
dc.subject.emtree | Adolescent | en_US |
dc.subject.emtree | Aged | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Benign neoplasm | en_US |
dc.subject.emtree | Brain cancer | en_US |
dc.subject.emtree | Brain damage | en_US |
dc.subject.emtree | Brain tissue | en_US |
dc.subject.emtree | Child | en_US |
dc.subject.emtree | Contrast enhancement | en_US |
dc.subject.emtree | Controlled study | en_US |
dc.subject.emtree | Female | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Image analysis | en_US |
dc.subject.emtree | Image display | en_US |
dc.subject.emtree | Image processing | en_US |
dc.subject.emtree | Intermethod comparison | en_US |
dc.subject.emtree | Interrater reliability | en_US |
dc.subject.emtree | Intracranial tumor | en_US |
dc.subject.emtree | Major clinical study | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | Nuclear magnetic resonance scanner | en_US |
dc.subject.emtree | Parenchyma | en_US |
dc.subject.emtree | Priority journal | en_US |
dc.subject.emtree | Retrospective study | en_US |
dc.subject.emtree | Signal detection | en_US |
dc.subject.emtree | Susceptibility weighted imaging | en_US |
dc.subject.emtree | White matter | en_US |
dc.subject.emtree | Adult | en_US |
dc.subject.emtree | Brain tumor | en_US |
dc.subject.emtree | Complication | en_US |
dc.subject.emtree | Computer assisted diagnosis | en_US |
dc.subject.emtree | Diagnostic imaging | en_US |
dc.subject.emtree | Image enhancement | en_US |
dc.subject.emtree | Magnetic resonance angiography | en_US |
dc.subject.emtree | Middle aged | en_US |
dc.subject.emtree | Neovascularization (pathology) | en_US |
dc.subject.emtree | Preschool child | en_US |
dc.subject.emtree | Procedures | en_US |
dc.subject.emtree | Reproducibility | en_US |
dc.subject.emtree | Sensitivity and specificity | en_US |
dc.subject.emtree | Young adult | en_US |
Appears in Collections: | Scopus Web of Science |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.